TJP1 and colitis: Geniposide ameliorates inflammation and mucosal damage in colitis (Xu et al., 2017; Zhang et al., 2017a), which is correlated to regulation on nuclear factor kappa B, peroxisome proliferator-activated receptor γ and MCL2 pathways and the expressions of ZO-1 and occludin.